CompletedPhase 2NCT01261429
Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT)
Studying Tenosynovial giant cell tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Centre Leon Berard
- Principal Investigator
- Jean Yves Blay, PRCentre Léon Bérard, Lyon
- Intervention
- Tasigna(drug)
- Enrollment
- 50 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2010 – 2013
Study locations (15)
- Institut Bergonié, Bordeaux, France
- Centre Oscar Lambret, Lille, France
- Centre Léon Bérard, Lyon, France
- Hôpital La Timone, Marseille, France
- Institut Paoli Calmettes, Marseille, France
- Institut Curie, Paris, France
- Institut Claudius Regaud, Toulouse, France
- Institut Gustave Roussy, Villejuif, France
- Istituto Nazionale dei Tumori, Milan, Italy
- Regina Elena National Cancer Institute, Roma, Italy
- Leiden University Medical Center, Leiden, Netherlands
- Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
- Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
- University College Hospital UCL Hospitals NHS Foundation Trust, London, United Kingdom
- Oxford Cancer Centre, Oxford, United Kingdom
Collaborators
Ministry of Health, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01261429 on ClinicalTrials.govOther trials for Tenosynovial giant cell tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07499362Study of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor (TGCT) (J-MANEUVER)Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- RECRUITINGPHASE4NCT07315841Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Tenosynovial Giant Cell Tumor SurgeryShanghai Jiao Tong University Affiliated Sixth People's Hospital
- RECRUITINGNCT07075471Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With VimseltinibDeciphera Pharmaceuticals, LLC
- ACTIVE NOT RECRUITINGPHASE3NCT05417789Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)SynOx Therapeutics Limited
- ACTIVE NOT RECRUITINGPHASE3NCT05804045Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)Abbisko Therapeutics Co, Ltd
- ACTIVE NOT RECRUITINGPHASE3NCT05059262Study of Vimseltinib for Tenosynovial Giant Cell TumorDeciphera Pharmaceuticals, LLC
- ACTIVE NOT RECRUITINGPHASE2NCT04703322A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in JapanDaiichi Sankyo Co., Ltd.
- RECRUITINGNCT04635111A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) TreatmentDaiichi Sankyo